Lastly, we did not observe changes in the CSF abundance of HB-EGF in patients with progressive MS, suggesting that its elevation is specific to acute stages of the disease (Extended Data Fig. 1g and Supplementary Table 2). This evidence concerns the gene HBEGF and myeloid sarcoma.